$REPL: Despite the 10–3 AdCom vote, I predict another CRL
FDA was not asking the AdCome to make the approval decision. The real value of an AdCom is whether the panel’s reasoning identifies something FDA missed or rebuts the review team’s concerns.
That did not happen.
Every
